Discovery and analysis of antisense oligonucleotide activity in cell culture

被引:24
作者
Baker, BF [1 ]
Condon, TP [1 ]
Koller, E [1 ]
McKay, RA [1 ]
Siwkowski, AM [1 ]
Vickers, TA [1 ]
Monia, BP [1 ]
机构
[1] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
D O I
10.1006/meth.2000.1120
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the past decade antisense oligonucleotides (ASOs) have proven to be a useful tool for dissection of gene function in molecular cell biology (Koller, E., Gaarde, W. A., and Monia, B. P. (2000) Trends Pharm. Sci., 21, 142-148), and validation of gene targets in animal models (Crooke, S. T. (1998) Biotechnol. Gen. Eng. Rev. 15, 121-157), as well as a means for therapeutic treatment of human diseases (Bennett, C. F. (1999) Exp. Opin. Invest. Drugs 8, 237-253). An important step toward usage of ASOs in the described applications is identification of an active ASO. This article describes the underlying basis and means for achieving this goal in cell culture. (C) 2001 Academic Press.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 56 条
  • [1] Altmann KH, 1996, CHIMIA, V50, P168
  • [2] Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides
    Arima, H
    Sakamoto, T
    Aramaki, Y
    Ishidate, K
    Tsuchiya, S
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (10) : 1079 - 1084
  • [3] Ausubel F.A., 1999, CURRENT PROTOCOLS MO
  • [4] 2'-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells
    Baker, BF
    Lot, SS
    Condon, TP
    ChengFlournoy, S
    Lesnik, EA
    Sasmor, HM
    Bennett, CF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) : 11994 - 12000
  • [5] BAKER BF, 1999, BIOCHIM BIOPHYS ACTA, V489, P3
  • [6] Antisense oligonucleotides as a tool for gene functionalization and target validation
    Bennett, CF
    Cowsert, LM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01): : 19 - 30
  • [7] Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture
    Bennett, CF
    Mirejovsky, D
    Crooke, RM
    Tsai, YJ
    Felgner, J
    Sridhar, CN
    Wheeler, CJ
    Felgner, PL
    [J]. JOURNAL OF DRUG TARGETING, 1998, 5 (03) : 149 - 162
  • [8] Bennett CF, 1993, J LIPOSOME RES, V3, P85
  • [9] ELECTROPORATION ENHANCES C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDE EFFICACY
    BERGAN, R
    CONNELL, Y
    FAHMY, B
    NECKERS, L
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (15) : 3567 - 3573
  • [10] BERGER SL, 1989, METHOD ENZYMOL, V180, P3